These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 8855941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF, Pandi L.
    Biochemistry; 2007 Sep 04; 46(35):10033-8. PubMed ID: 17688324
    [Abstract] [Full Text] [Related]

  • 4. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM, Song Y, Sheng D, Ball EL, Matsueda GR.
    Thromb Haemost; 1995 Sep 04; 74(3):923-7. PubMed ID: 8571322
    [Abstract] [Full Text] [Related]

  • 5. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
    Matsumoto F, Uzuki M, Kaneko C, Rikimaru A, Kokubun S, Sawai T.
    Ryumachi; 1997 Oct 04; 37(5):688-95. PubMed ID: 9396371
    [Abstract] [Full Text] [Related]

  • 6. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
    Schönbeck U, Mach F, Libby P.
    J Immunol; 1998 Oct 01; 161(7):3340-6. PubMed ID: 9759850
    [Abstract] [Full Text] [Related]

  • 7. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
    Webster L, Chignell AH, Limb GA.
    Exp Eye Res; 1999 Jan 01; 68(1):91-8. PubMed ID: 9986746
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Feb 01; 81(2):268-74. PubMed ID: 10064005
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S, Lehti K, Keski-Oja J, Mignatti P.
    J Cell Physiol; 2002 Aug 01; 192(2):160-70. PubMed ID: 12115722
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T, Tchetina E, Ohsawa K, Roughley PJ, Wu W, Mousa A, Ionescu M, Pidoux I, Poole AR.
    Matrix Biol; 2006 Sep 01; 25(7):419-29. PubMed ID: 16919430
    [Abstract] [Full Text] [Related]

  • 19. [Matrix metalloproteinases and their biological functions].
    Solov'eva NI.
    Bioorg Khim; 1998 Apr 01; 24(4):245-55. PubMed ID: 9612566
    [Abstract] [Full Text] [Related]

  • 20. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P.
    EMBO J; 1997 May 01; 16(9):2319-32. PubMed ID: 9171346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.